Correlation Between Sunshine Biopharma and Sharps Technology
Can any of the company-specific risk be diversified away by investing in both Sunshine Biopharma and Sharps Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunshine Biopharma and Sharps Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sunshine Biopharma Warrant and Sharps Technology Warrant, you can compare the effects of market volatilities on Sunshine Biopharma and Sharps Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunshine Biopharma with a short position of Sharps Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunshine Biopharma and Sharps Technology.
Diversification Opportunities for Sunshine Biopharma and Sharps Technology
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Sunshine and Sharps is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Sunshine Biopharma Warrant and Sharps Technology Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sharps Technology Warrant and Sunshine Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunshine Biopharma Warrant are associated (or correlated) with Sharps Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sharps Technology Warrant has no effect on the direction of Sunshine Biopharma i.e., Sunshine Biopharma and Sharps Technology go up and down completely randomly.
Pair Corralation between Sunshine Biopharma and Sharps Technology
Assuming the 90 days horizon Sunshine Biopharma Warrant is expected to generate 1.86 times more return on investment than Sharps Technology. However, Sunshine Biopharma is 1.86 times more volatile than Sharps Technology Warrant. It trades about 0.32 of its potential returns per unit of risk. Sharps Technology Warrant is currently generating about -0.15 per unit of risk. If you would invest 7.70 in Sunshine Biopharma Warrant on August 28, 2024 and sell it today you would earn a total of 14.30 from holding Sunshine Biopharma Warrant or generate 185.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 86.36% |
| Values | Daily Returns |
Sunshine Biopharma Warrant vs. Sharps Technology Warrant
Performance |
| Timeline |
| Sunshine Biopharma |
| Sharps Technology Warrant |
Sunshine Biopharma and Sharps Technology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sunshine Biopharma and Sharps Technology
The main advantage of trading using opposite Sunshine Biopharma and Sharps Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunshine Biopharma position performs unexpectedly, Sharps Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sharps Technology will offset losses from the drop in Sharps Technology's long position.| Sunshine Biopharma vs. Sunshine Biopharma | Sunshine Biopharma vs. Thayer Ventures Acquisition | Sunshine Biopharma vs. Biofrontera Warrants | Sunshine Biopharma vs. Neurosense Therapeutics |
| Sharps Technology vs. Sharps Technology | Sharps Technology vs. Tenon Medical | Sharps Technology vs. Scisparc | Sharps Technology vs. OKYO Pharma Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |